Immunotherapy in Ovarian Cancer: Immunotherapy, an innovative cancer treatment, is being investigated for its potential in ovarian cancer. While traditionally less responsive to immunotherapy, recent advances show promise. Checkpoint inhibitors like pembrolizumab and nivolumab, along with PARP inhibitors, are being explored. Combination therapies, pairing immunotherapy with chemotherapy or targeted treatments, aim to enhance efficacy. Identifying biomarkers is crucial for personalized treatment. Ongoing clinical trials seek to refine strategies, offering hope for improved outcomes. Individual responses may vary, emphasizing the need for personalized care. Patients should discuss immunotherapy and other options with their healthcare team for informed decisions in the evolving landscape of ovarian cancer research and treatment. #Gynecologist_near_me #Top_10_gynecologist